Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART-Reference-Cited by-同舟云学术

Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART

Published:2005-04-11 Issue:6 Volume:55 Page:1003-1007
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Bongiovanni Marco,Chiesa Elisabetta,Di Biagio Antonio,Meraviglia Paola,Capetti Amedeo,Tordato Federica,Cicconi Paola,Biasi Patrizia,Bini Teresa,d'Arminio Monforte Antonella

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/55/6/1003/2155267/dki113.pdf

Reference21 articles.

1. Palella, F. J., Delaney, K. M., Moorman, A. C. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine338, 853–60.

2. Mocroft, A., Vella, S., Benfield, T. L. et al. (1998). Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet352, 1725–33.

3. Hoggs, R. S., O'Shaughnessy, M. V., Gataric, N. et al. (1997). Decline in deaths from AIDS due to new antiretrovirals. Lancet349, 1294.

4. Detels, R., Munoz, A., McFarlane, G. et al. (1998). Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Journal of the American Medical Association280, 1497–503.

5. d'Arminio Manforte, A., Cozzi Lepri, A., Rezza, G. et al. (2000). Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. AIDS14, 499–507.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel method for preparing stabilized amorphous solid dispersion drug formulations using acoustic fusion;International Journal of Pharmaceutics;2021-01

2. Pharmacotherapy of COVID-19: confine to existential drugs or search for new ones? (Preprint);2020-07-10

3. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children;Journal of Antimicrobial Chemotherapy;2007-11-22

4. Plasma Concentrations of the HIV-Protease Inhibitor Lopinavir are Suboptimal in Children Aged 2 Years and Below;Antiviral Therapy;2007-05